| 1 |
Ge X, Gu Y, Li D, Jiang M, Zhao S, Li Z, Liu S. Knockdown of lncRNA PCAT1 Enhances Radiosensitivity of Cervical Cancer by Regulating miR-128/GOLM1 Axis. Onco Targets Ther 2020;13:10373-85. [PMID: 33116617 DOI: 10.2147/OTT.S263728] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 2 |
Yan J, Zhou B, Li H, Guo L, Ye Q. Recent advances of GOLM1 in hepatocellular carcinoma. Hepat Oncol 2020;7:HEP22. [PMID: 32647567 DOI: 10.2217/hep-2020-0006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 3 |
Singh G, Yoshida EM, Rathi S, Marquez V, Kim P, Erb SR, Salh BS. Biomarkers for hepatocellular cancer. World J Hepatol 2020; 12(9): 558-573 [PMID: 33033565 DOI: 10.4254/wjh.v12.i9.558] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 4 |
Shen JG, Shen J, Teng RY, Wang LB, Zhao WH, Wang QC. High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study. Pathol Oncol Res 2021;27:603838. [PMID: 34257562 DOI: 10.3389/pore.2021.603838] [Reference Citation Analysis]
|
| 5 |
Gupta R, Kleinjans J, Caiment F. Identifying novel transcript biomarkers for hepatocellular carcinoma (HCC) using RNA-Seq datasets and machine learning. BMC Cancer 2021;21:962. [PMID: 34445986 DOI: 10.1186/s12885-021-08704-9] [Reference Citation Analysis]
|
| 6 |
Shao W, Wang T, Sun L, Dong T, Han Z, Huang Z, Zhang J, Zhang D, Huang K. Multi-task multi-modal learning for joint diagnosis and prognosis of human cancers. Medical Image Analysis 2020;65:101795. [DOI: 10.1016/j.media.2020.101795] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 7 |
Gatselis NK, Tornai T, Shums Z, Zachou K, Saitis A, Gabeta S, Albesa R, Norman GL, Papp M, Dalekos GN. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients. World J Gastroenterol 2020; 26(34): 5130-5145 [PMID: 32982114 DOI: 10.3748/wjg.v26.i34.5130] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Xia Y, Zhang Y, Shen M, Xu H, Li Z, He N. Golgi protein 73 and its diagnostic value in liver diseases. Cell Prolif 2019;52:e12538. [PMID: 30341783 DOI: 10.1111/cpr.12538] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 9 |
Zong J, Fan Z, Zhang Y. Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma. J Hepatocell Carcinoma 2020;7:413-22. [PMID: 33376710 DOI: 10.2147/JHC.S272762] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 10 |
Liang R, Liu Z, Piao X, Zuo M, Zhang J, Liu Z, Li Y, Lin Y. Research progress on GP73 in malignant tumors. Onco Targets Ther 2018;11:7417-21. [PMID: 30425529 DOI: 10.2147/OTT.S181239] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 11 |
Ding X, Deng G, Liu J, Liu B, Yuan F, Yang X, Chen Q. GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt/β-catenin signaling pathway. Brain Res 2019;1717:117-26. [PMID: 30935831 DOI: 10.1016/j.brainres.2019.03.035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
|
